Goldman Sachs Group »

Syndax Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 1.3M 21.61
2023-09-30 $18M 1.3M 14.52
2023-06-30 $16M 746k 20.93
2023-03-31 $10M 491k 21.12
2022-12-31 $11M 438k 25.45
2022-06-30 $11M 546k 19.24
2022-03-31 $7.1M 408k 17.38
2021-12-31 $8.0M 364k 21.89
2021-09-30 $6.1M 320k 19.11
2021-03-31 $13M 564k 22.36
2020-12-31 $12M 554k 22.24
2020-09-30 $3.7M 252k 14.76
2020-06-30 $6.5M 438k 14.81
2019-12-31 $545k 62k 8.79
2019-09-30 $170k 23k 7.48
2019-06-30 $241k 26k 9.29
2019-03-31 $75k 14k 5.22
2018-12-31 $235k 53k 4.41
2018-09-30 $537k 66k 8.09
2018-06-30 $527k 75k 7.02
2018-03-31 $234k 16k 14.26
2017-12-31 $515k 59k 8.77
2016-03-31 $353k 27k 13.32